Achilles Corporation AI Stock Analysis
Want to see JP:5142 full AI Analyst Report?
Achilles Corporation (5142) AI Stock Analysis
Achilles Corporation
(TSE/TYO:5142)
Score of 62 driven primarily by moderate financial performance with revenue and earnings recovery, tempered by weak technical momentum, while attractive valuation offers support.
Achilles Corporation (5142) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 25.34B
- Dividend Yield
- 2.21%
- Average Volume (3M)
- 92.79K
- Price to Earnings (P/E)
- 8.8
- Beta (1Y)
- 1.46
- Revenue Growth
- 7.74%
- EPS Growth
- 350.67%
- Country
- Japan
- Employees
- 1,596
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Achilles Corporation Business Overview & Revenue Model
Company Description
Achilles Corporation, a Tokyo-based company founded in 1947 and formerly known as Kohkoku Chemical Industry until its 1982 rebranding, is a diverse manufacturer and supplier of footwear, plastic goods, and industrial materials. While maintaining a st...
Achilles Corporation Financial Statement Overview
Summary
Moderate performance with revenue growth to 81.8 billion and earnings recovery to 2.1 billion in 2026, supported by stable assets, but offset by volatile cash flows and rising leverage to 0.40.
Income Statement
65PositiveBalance Sheet
70PositiveCash Flow
55Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.78B | 81.80B | 79.09B | 78.61B | 82.92B | 75.95B |
| Gross Profit | 18.30B | 17.52B | 14.19B | 14.18B | 14.85B | 15.66B |
| EBITDA | 6.63B | 5.71B | 3.81B | -1.21B | 2.13B | 5.42B |
| Net Income | 2.89B | 2.12B | 427.00M | -8.21B | -1.20B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 86.57B | 83.63B | 79.50B | 82.66B | 86.22B | 80.12B |
| Cash, Cash Equivalents and Short-Term Investments | 9.96B | 9.75B | 7.72B | 6.85B | 6.89B | 7.59B |
| Total Debt | 17.15B | 17.15B | 14.65B | 14.65B | 11.10B | 5.20B |
| Total Liabilities | 42.13B | 40.34B | 40.17B | 43.11B | 40.01B | 32.39B |
| Stockholders Equity | 44.44B | 43.28B | 39.34B | 39.55B | 46.21B | 47.73B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -238.00M | -1.11B | -2.37B | -5.91B | -1.41B |
| Operating Cash Flow | 0 | 2.64B | 2.69B | 1.88B | -1.07B | 4.71B |
| Investing Cash Flow | 0 | -2.86B | -1.92B | -3.79B | -4.48B | -5.03B |
| Financing Cash Flow | 0 | 2.15B | -1.25B | 1.76B | 4.55B | -860.00M |
Achilles Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5142, the sentiment is Positive. The current price of 1813.00 is below the 20-day moving average (MA) of 1816.60, below the 50-day MA of 1846.92, and above the 200-day MA of 1521.96, indicating a neutral trend. The MACD of -36.78 indicates Positive momentum. The RSI at 50.38 is Neutral, neither overbought nor oversold. The STOCH value of 56.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5142.
Achilles Corporation Peers Comparison
Overall Rating
JP:501384Outperform
JP:514262Neutral
JP:497061Neutral
JP:355352Neutral
JP:453149Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | JPY 41.58B | 9.66 | ― | 3.92% | -0.92% | 0.66% | |
| 62Neutral | JPY 25.47B | 8.79 | ― | 2.21% | 7.74% | 350.67% | |
| 61Neutral | JPY 56.75B | 16.31 | ― | 0.66% | 20.83% | 89.46% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 52Neutral | JPY 21.36B | 22.96 | ― | 5.94% | 4.28% | 67.90% | |
| 49Neutral | JPY 7.29B | 15.03 | ― | 3.00% | 3.90% | -31.32% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:5142 | Achilles Corporation | 1813.00 | 542.37 | 42.68% | |
| JP:3553 | Kyowa Leather Cloth Co., Ltd. | 875.00 | 50.85 | 6.17% | |
| JP:4531 | Yuki Gosei Kogyo Co., Ltd. | 333.00 | 56.01 | 20.22% | |
| JP:4970 | Toyo Gosei Co., Ltd. | 7610.00 | 1079.83 | 16.54% | |
| JP:5013 | Yushiro Chemical Industry Co., Ltd. | 3110.00 | 936.11 | 43.06% |
Achilles Corporation Corporate Events
Achilles Reshapes Operating Officer Roles in Production Division
Achilles Corporation has announced changes to its operating officer structure following a Board of Directors resolution on September 28, 2026, reflecting a reorganization of responsibilities in its production operations. Yukiyoshi Omori has been prom...
Achilles to Halt Production at Loss-Making Chinese Automotive Materials Subsidiary
Achilles Corporation has decided to discontinue production at its wholly owned Chinese subsidiary, Achilles (Foshan) New Materials, which was established in 2019 to expand its automotive materials business. The unit has faced a persistently difficult...
Achilles Books ¥1.38 Billion Extraordinary Gain on Sale of Investment Securities
Achilles Corporation has completed the sale of five listed stocks it held as investment securities, generating a gain of 1,383 million yen that slightly exceeded its earlier forecast of approximately 1,300 million yen. The sale is part of the company...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
